Press release from CNW Group
Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference
Monday, May 20, 2013
Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference17:01 EDT Monday, May 20, 2013
LAVAL, Quebec, May 20, 2013 /CNW/ - Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced members of its senior management team will make a presentation at the 34th Annual Goldman Sachs Healthcare Conference on Tuesday, June 11, 2013 at 9:20 a.m. PT. The conference will be held at the Terranea Resort in Los Angeles, CA.
A live webcast and audio archive of the presentation will be available on the company's Web site at www.valeant.com. Click on Investor Relations, and then the link to Events and Presentations. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast.
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology and branded generics. More information about Valeant can be found at www.valeant.com.
Laurie W. Little
SOURCE: Valeant Pharmaceuticals International, Inc.
For further information: